News Sentiment

BLCO sentiment intelligence

Bausch + Lomb Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 49 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 16.23 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-5.4% over one week, +7.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Negative

Bausch + Lomb's BL1107 fails primary end point in Phase 2 glaucoma trial

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -5.4% Price reacting lower
Trend fit Trend inactive 7.6% over four weeks
Fair value 1.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 23
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
TradingView 4
Stock Titan 3
Optometry Times 2
BioSpace 2
VisionMonday.com 2
Reuters 2
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 12
Regulatory and legal 3
Analyst action 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49